异动解读 | CureVac盘前大涨28.99%,BioNTech拟12.5亿美元收购

异动解读
Jun 12, 2025

生物科技公司CureVac B.V.(股票代码:CVAC)今日盘前大涨28.99%,引发市场高度关注。

根据最新消息,德国生物科技巨头BioNTech计划以12.5亿美元收购CureVac,此举旨在增强BioNTech的癌症业务。这一收购消息成为推动CureVac股价大幅上涨的主要原因。

此次收购对双方都具有重要意义。对BioNTech而言,收购CureVac将有助于其扩大在癌症治疗领域的布局,进一步增强其在生物科技行业的竞争力。对CureVac来说,被行业巨头收购不仅能为公司带来可观的溢价,还可能为其研发项目提供更多资源和支持。市场对这一潜在的协同效应反应积极,推动CureVac股价在盘前交易中大幅上涨。投资者们将密切关注这一收购交易的进展及其对两家公司未来发展的影响。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10